|

Full course of PD-1/PD-L1 blockades Clinical Trials

2 actively recruiting trials

Pipeline

Phase 3: 2

Top Sponsors

  • Sun Yat-sen University2

Indications

  • De-escalation Therapy2
  • Nasopharyngeal Carcinoma2
  • Cancer2

Other2 trials

Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy
Phase 3
Under Whole-course of Immunotherapy, Gradient Fractionated RT with CCT Versus CFRT with CCT for LANPC Who Achieved PR Post Induction Chemotherapy.
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.